- Home
- BLLN vs ASB Comparison
BLLN vs ASB Comparison
Compare BLLN & ASB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BLLN | ASB |
|---|---|---|
| Founded | 2016 | 1861 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 4.5B |
| IPO Year | 2025 | N/A |
Fundamental Metrics
Financial Performance| Metric | BLLN | ASB |
|---|---|---|
| Price | $87.17 | $26.51 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 12 |
| Target Price | ★ $137.83 | $28.00 |
| AVG Volume (30 Days) | 259.9K | ★ 2.1M |
| Earning Date | 12-09-2025 | 01-22-2026 |
| Dividend Yield | N/A | ★ 3.62% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.98 |
| Revenue | $254,136,000.00 | ★ $1,097,713,000.00 |
| Revenue This Year | $98.01 | $57.95 |
| Revenue Next Year | $35.84 | $10.63 |
| P/E Ratio | ★ N/A | $27.05 |
| Revenue Growth | ★ 254.30 | 8.93 |
| 52 Week Low | $80.51 | $18.32 |
| 52 Week High | $138.70 | $27.58 |
Technical Indicators
Market Signals| Indicator | BLLN | ASB |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 53.50 |
| Support Level | N/A | $25.94 |
| Resistance Level | N/A | $27.05 |
| Average True Range (ATR) | 0.00 | 0.62 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 0.00 | 65.84 |
Price Performance
Historical ComparisonAbout BLLN BillionToOne Inc.
BillionToOne Inc is a precision diagnostics company revolutionizing molecular testing with its patented Quantitative Counting Templates (QCT) platform. This technology enables ultrasensitive, single-molecule DNA quantification, making genetic testing more accurate, affordable, and accessible. The company serves prenatal screening and oncology markets with non-invasive tests that detect fetal genetic risks and monitor cancer therapy response.
About ASB Associated Banc-Corp
Associated Banc-Corp is a bank holding company. The company through its subsidiaries provides a broad array of banking and nonbanking products and services to individuals and businesses. The company operates in three reportable segments; Corporate and Commercial Specialty; Community, Consumer, and Business; and Risk Management and Shared Services. The majority of its revenue is derived from the Corporate and Commercial Specialty and Community, Consumer, and Business segments.